Agilent Technologies, Inc. (A): Price and Financial Metrics
Agilent Technologies, Inc. (A)
Today's Latest Price: $79.29 USD
1.35 (1.73%)
Updated Nov 19 12:00am
Add A to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 51 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
A Stock Summary
- With a market capitalization of $23,748,549,610, Agilent Technologies Inc has a greater market value than 91.86% of US stocks.
- Price to trailing twelve month operating cash flow for A is currently 22.01, higher than 79.73% of US stocks with positive operating cash flow.
- In terms of volatility of its share price, A is more volatile than just 21.74% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Agilent Technologies Inc, a group of peers worth examining would be RMD, SSD, TYL, WAT, and EBAY.
- A's SEC filings can be seen here. And to visit Agilent Technologies Inc's official web site, go to www.agilent.com.
A Daily Price Range
A 52-Week Price Range
A Stock Price Chart More Charts
A Price/Volume Stats
| Current price | $79.29 |
| Prev. close | $77.94 |
| Day low | $77.84 |
| Day high | $79.49 |
| 50-day MA | $76.08 |
| 200-day MA | $74.66 |
| 52-week high | $82.27 |
| 52-week low | $62.00 |
| Volume | 1,704,700 |
| Avg. volume | 2,208,107 |
| Dividend yield | 0.83% |
| Market Cap | 24.54B |
Agilent Technologies, Inc. (A) Company Bio
Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.
Top Stories View All
Is Cannabis Stock Aurora Cannabis (ACB) a Buy?
Best & Worst Performing Stock Industries for November 19, 2019
Best & Worst Performing Small Cap Stocks for November 19, 2019
Best & Worst Performing Mid Cap Stocks for November 19, 2019
Best & Worst Performing Large Cap Stocks for November 19, 2019
View All Top Stories
Loading social stream, please wait...